1. Home
  2. GNPX vs RKDA Comparison

GNPX vs RKDA Comparison

Compare GNPX & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • RKDA
  • Stock Information
  • Founded
  • GNPX 2009
  • RKDA 2002
  • Country
  • GNPX United States
  • RKDA United States
  • Employees
  • GNPX N/A
  • RKDA N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • RKDA Agricultural Chemicals
  • Sector
  • GNPX Health Care
  • RKDA Industrials
  • Exchange
  • GNPX Nasdaq
  • RKDA Nasdaq
  • Market Cap
  • GNPX 5.5M
  • RKDA 5.8M
  • IPO Year
  • GNPX 2018
  • RKDA 2015
  • Fundamental
  • Price
  • GNPX $0.31
  • RKDA $3.58
  • Analyst Decision
  • GNPX
  • RKDA
  • Analyst Count
  • GNPX 0
  • RKDA 0
  • Target Price
  • GNPX N/A
  • RKDA N/A
  • AVG Volume (30 Days)
  • GNPX 23.7M
  • RKDA 10.3K
  • Earning Date
  • GNPX 08-14-2025
  • RKDA 11-11-2025
  • Dividend Yield
  • GNPX N/A
  • RKDA N/A
  • EPS Growth
  • GNPX N/A
  • RKDA N/A
  • EPS
  • GNPX N/A
  • RKDA N/A
  • Revenue
  • GNPX N/A
  • RKDA $5,407,000.00
  • Revenue This Year
  • GNPX N/A
  • RKDA $21.31
  • Revenue Next Year
  • GNPX N/A
  • RKDA $28.33
  • P/E Ratio
  • GNPX N/A
  • RKDA N/A
  • Revenue Growth
  • GNPX N/A
  • RKDA 23.79
  • 52 Week Low
  • GNPX $0.14
  • RKDA $2.53
  • 52 Week High
  • GNPX $3.97
  • RKDA $10.31
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 69.58
  • RKDA 47.59
  • Support Level
  • GNPX $0.20
  • RKDA $3.03
  • Resistance Level
  • GNPX $0.40
  • RKDA $3.28
  • Average True Range (ATR)
  • GNPX 0.04
  • RKDA 0.23
  • MACD
  • GNPX 0.02
  • RKDA 0.00
  • Stochastic Oscillator
  • GNPX 61.56
  • RKDA 67.63

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

Share on Social Networks: